173 related articles for article (PubMed ID: 12967337)
1. Interferon-alpha reduces insulin resistance and beta-cell secretion in responders among patients with chronic hepatitis B and C.
Tai TY; Lu JY; Chen CL; Lai MY; Chen PJ; Kao JH; Lee CZ; Lee HS; Chuang LM; Jeng YM
J Endocrinol; 2003 Sep; 178(3):457-65. PubMed ID: 12967337
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin levels among patients with chronic hepatitis B and C infections and in response to IFN-alpha therapy.
Lu JY; Chuang LM; Yang WS; Tai TY; Lai MY; Chen PJ; Kao JH; Lee CZ; Lee HS
Liver Int; 2005 Aug; 25(4):752-9. PubMed ID: 15998426
[TBL] [Abstract][Full Text] [Related]
3. Trajectories of anti-islet autoantibodies before development of type 1 diabetes in interferon-treated hepatitis C patients. Case reports and a literature review.
Nakamura K; Kawasaki E; Abiru N; Jo O; Fukushima K; Satoh T; Kuriya G; Kobayashi M; Kuwahara H; Yamasaki H; Ide T; Eguchi K
Endocr J; 2010; 57(11):947-51. PubMed ID: 20805634
[TBL] [Abstract][Full Text] [Related]
4. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
Greenbaum CJ; Prigeon RL; D'Alessio DA
Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
[TBL] [Abstract][Full Text] [Related]
5. Pilot study of combination therapy with ribavirin and interferon alfa for the retreatment of chronic hepatitis B e antibody-positive patients.
Cotonat T; Quiroga JA; López-Alcorocho JM; Clouet R; Pardo M; Manzarbeitia F; Carreño V
Hepatology; 2000 Feb; 31(2):502-6. PubMed ID: 10655277
[TBL] [Abstract][Full Text] [Related]
6. Peg-interferon improves liver histology in patients with HBeAg-positive chronic hepatitis B: no additional benefit of combination with lamivudine.
van Zonneveld M; Zondervan PE; Cakaloglu Y; Simon C; Akarca US; So TM; Flink HJ; de Man RA; Schalm SW; Janssen HL;
Liver Int; 2006 May; 26(4):399-405. PubMed ID: 16629642
[TBL] [Abstract][Full Text] [Related]
7. A case of chronic hepatitis C developing insulin-dependent diabetes mellitus associated with various autoantibodies during interferon therapy.
Uto H; Matsuoka H; Murata M; Okamoto T; Miyata Y; Hori T; Ido A; Hirono S; Hayashi K; Tsubouchi H
Diabetes Res Clin Pract; 2000 Aug; 49(2-3):101-6. PubMed ID: 10963820
[TBL] [Abstract][Full Text] [Related]
8. Effects of long-term interferon-alpha treatment on glucose tolerance in patients with chronic hepatitis C.
Ito Y; Takeda N; Ishimori M; Akai A; Miura K; Yasuda K
J Hepatol; 1999 Aug; 31(2):215-20. PubMed ID: 10453932
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B: a randomized controlled study.
You J; Zhuang L; Cheng HY; Yan SM; Yu L; Huang JH; Tang BZ; Huang ML; Ma YL; Chongsuvivatwong V; Sriplung H; Geater A; Qiao YW; Wu RX
World J Gastroenterol; 2006 Nov; 12(41):6715-21. PubMed ID: 17075991
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of Japanese patients with chronic hepatitis B treated with interferon-alpha.
Truong BX; Seo Y; Kato M; Hamano K; Ninomiya T; Katayama M; Kato H; Yano Y; Hayashi Y; Kasuga M
Int J Mol Med; 2005 Aug; 16(2):279-84. PubMed ID: 16012762
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon-alpha.
Konrad T; Zeuzem S; Vicini P; Toffolo G; Briem D; Lormann J; Herrmann G; Berger A; Kusterer K; Teuber G; Cobelli C; Usadel KH
Eur J Clin Invest; 2000 Feb; 30(2):111-21. PubMed ID: 10651835
[TBL] [Abstract][Full Text] [Related]
12. Development of insulin-dependent diabetes mellitus in a patient with chronic hepatitis C during therapy with interferon-alpha.
Eibl N; Gschwantler M; Ferenci P; Eibl MM; Weiss W; Schernthaner G
Eur J Gastroenterol Hepatol; 2001 Mar; 13(3):295-8. PubMed ID: 11293453
[TBL] [Abstract][Full Text] [Related]
13. Prediction of treatment-related HBsAg loss in HBeAG-negative chronic hepatitis B: a clue from serum HBsAg levels.
Manesis EK; Hadziyannis ES; Angelopoulou OP; Hadziyannis SJ
Antivir Ther; 2007; 12(1):73-82. PubMed ID: 17503750
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of beta-cell secretory capacity using glucagon-like peptide 1.
Vilsbøll T; Toft-Nielsen MB; Krarup T; Madsbad S; Dinesen B; Holst JJ
Diabetes Care; 2000 Jun; 23(6):807-12. PubMed ID: 10841001
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.
van Zonneveld M; Honkoop P; Hansen BE; Niesters HG; Darwish Murad S; de Man RA; Schalm SW; Janssen HL
Hepatology; 2004 Mar; 39(3):804-10. PubMed ID: 14999700
[TBL] [Abstract][Full Text] [Related]
16. Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2.
Stancek D; Fuchsberger N; Oltman M; Schmeisser H; Kontsek P; Jahnová E; Hajnická V
Acta Virol; 2001; 45(5-6):287-92. PubMed ID: 12083327
[TBL] [Abstract][Full Text] [Related]
17. Glucagon receptor antagonism improves islet function in mice with insulin resistance induced by a high-fat diet.
Winzell MS; Brand CL; Wierup N; Sidelmann UG; Sundler F; Nishimura E; Ahrén B
Diabetologia; 2007 Jul; 50(7):1453-62. PubMed ID: 17479245
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of pegylated interferon-α-2a in chronic hepatitis B: a multicenter clinical experience.
Ratnam D; Dev A; Nguyen T; Sundararajan V; Harley H; Cheng W; Lee A; Rusli F; Chen R; Bell S; Pianko S; Sievert W
J Gastroenterol Hepatol; 2012 Sep; 27(9):1447-53. PubMed ID: 22168789
[TBL] [Abstract][Full Text] [Related]
19. Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection.
Betterle C; Fabris P; Zanchetta R; Pedini B; Tositti G; Bosi E; de Lalla F
Diabetes Care; 2000 Aug; 23(8):1177-81. PubMed ID: 10937518
[TBL] [Abstract][Full Text] [Related]
20. HBV DNA suppression in HBeAg-positive chronic hepatitis B patients treated with peginterferon or placebo.
Hansen BE; Rijckborst V; Ter Borg MJ; Janssen HL
J Med Virol; 2011 Nov; 83(11):1917-23. PubMed ID: 21915866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
